You are here: / Kontaktieren Sie uns
This past May, FDA issued a new guidance for industry concerning the submission of summary bioequivalence data for abbreviated new drug applications (ANDAs). The guidance is meant to clarify the requirements for the submission of bioequivalence data that were published in 2009 (1). Federal regulations require that all bioequivalence studies performed for a given agent […]
ADPEN Laboratories, Inc.
11757 Central Parkway
Jacksonville, FL 32224 USA
Fax: (904) 641-8423